Switch Between GLP-1 Medications With Confidence
Wegovy or Mounjaro Which Is Better for Switching Patients?
When considering wegovy or mounjaro which is better for your situation, the answer often depends on your individual response to GLP-1 medications and specific circumstances. Many patients switch between these prescription-only medicines for various reasons including side effect profiles, cost considerations, or medication availability. Wegovy contains semaglutide, a pure GLP-1 receptor agonist, whilst Mounjaro uses tirzepatide, which targets both GIP and GLP-1 receptors simultaneously. This dual mechanism may offer different tolerability profiles, though individual responses vary significantly between patients.
The switching process requires careful clinical oversight, as both medications follow specific dose escalation schedules that cannot be bypassed safely. Your prescriber will determine appropriate conversion dosing based on your current medication, dose, and clinical response. At EverydayMeds (GPhC #9012878), we support patients switching between both treatments, ensuring continuity of care throughout your transition period. Our clinical assessment captures your current medication history to facilitate safe switching protocols under prescriber guidance.
Pricing Comparison: Wegovy vs Mounjaro Switch Costs
Understanding the cost implications when deciding wegovy or mounjaro which is better helps inform your switching decision. Wegovy pricing at EverydayMeds starts from £79.99 for the 0.25mg starter dose, progressing to £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), and £209.99 for the 2.4mg maintenance dose. New customers apply discount code FIRST40 at checkout, whilst returning customers use DOSE25 to reach these final prices. Our bundle options provide convenient multi-month supplies, such as the Intro Trio (0.25mg, 0.5mg, 1mg) for £299.99, supporting your complete dose escalation journey.
Mounjaro pricing follows a different structure given its unique dosing schedule, though both medications are available through the same streamlined ordering process. The financial impact of switching depends on your current dose and target maintenance level, with potential savings varying by individual circumstances. Patients switching often find our transparent pricing model refreshing compared to inconsistent pharmacy pricing elsewhere. Our bundle pricing eliminates the uncertainty of individual pen purchases, providing Reliable Supply continuity during your switching period without unexpected cost fluctuations.
Clinical Evidence: Understanding Wegovy or Mounjaro Which Is Better
When evaluating wegovy or mounjaro which is better from a clinical perspective, both medications demonstrate significant efficacy in clinical trials, though direct head-to-head comparisons are limited due to different trial designs and patient populations. Wegovy's STEP 1 trial showed patients achieved approximately 15% average weight loss at 68 weeks alongside a reduced-calorie diet and increased physical activity, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP programme encompassed diverse patient groups, including those with type 2 diabetes (STEP 2) and intensive behavioural therapy participants (STEP 3).
Mounjaro's SURMOUNT trials demonstrated substantial weight reductions with its dual GIP/GLP-1 mechanism, though comparing percentages directly between trials can be misleading due to different study protocols and baseline characteristics. Both medications require prescription-only access and must be used alongside lifestyle modifications for optimal outcomes. The choice between treatments often comes down to individual tolerability, dosing preferences, and practical considerations rather than superior efficacy claims.
How Wegovy Works for Weight Management
Wegovy functions as a GLP-1 receptor agonist, mimicking your body's natural glucagon-like peptide-1 hormone that regulates appetite and satiety signals. The medication works primarily on appetite centres in your brain, reducing hunger sensations and promoting feelings of fullness after smaller meals. This mechanism may help reduce food cravings and portion sizes naturally, supporting your weight management efforts alongside dietary changes. Wegovy also slows gastric emptying, meaning food stays in your stomach longer, contributing to sustained satiety between meals. The once-weekly injection schedule using the FlexTouch pen device provides consistent medication levels throughout the week, maintaining appetite suppression effects. Understanding this mechanism helps explain why Wegovy must be combined with a reduced-calorie diet and increased physical activity for optimal weight management outcomes.
Ordering Process: Seamless Switching Support
Our streamlined ordering process supports patients considering wegovy or mounjaro which is better through a comprehensive 3-minute online clinical assessment. This assessment captures your current medication history, including any previous GLP-1 treatments, side effects experienced, and switching motivations to inform prescriber decisions. Following submission, our prescribers review your case within 3 working days (or 24 hours with express service), determining suitability and appropriate dosing for your transition. Once approved, your medication ships via next-day delivery using temperature-controlled cold-chain logistics to maintain medication integrity. Our GPhC-registered pharmacy (#9012878) ensures all switching protocols follow MHRA guidelines for prescription-only medicines. The entire process eliminates common switching barriers like finding new prescribers or pharmacy transfers, providing continuity throughout your medication change.
Storage and Practical Considerations
Storage requirements often influence decisions about wegovy or mounjaro which is better for your lifestyle. Wegovy offers superior storage flexibility, remaining stable at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. This advantage proves valuable for travel, workplace storage, or situations where refrigeration access is limited. Both medications require initial refrigerated storage at 2-8°C before first use, though Wegovy's extended room temperature stability provides greater convenience for many patients. The FlexTouch pen design delivers consistent doses with minimal injection site reactions when proper injection technique is followed. Dose escalation schedules differ between medications, with Wegovy following a structured 4-week progression through each dose level until reaching your maintenance dose.
Switching Strategies: When Changing Medications Makes Sense
Patients typically consider switching when asking wegovy or mounjaro which is better due to side effect concerns, cost considerations, or inadequate response to their current treatment. Common switching scenarios include gastrointestinal intolerance that doesn't improve with dose adjustments, medication supply issues, or insurance coverage changes affecting affordability. Some patients switch to access different injection schedules or pen designs that better suit their preferences and lifestyle requirements. The dual mechanism of Mounjaro may offer different tolerability profiles for patients who experience persistent side effects with single-target GLP-1 medications like Wegovy.
Switching between these medications requires careful timing and clinical supervision to maintain therapeutic benefits whilst minimising side effects during transition. Your prescriber will typically recommend a washout period or direct conversion protocol based on your current dose and clinical response. At EverydayMeds, we coordinate with your healthcare provider to ensure switching protocols follow best practice guidelines for prescription-only medicines. This collaborative approach reduces switching complications and maintains momentum in your weight management journey throughout the medication change.
Expert Guidance: Making Your Switch Decision
Rather than determining definitively wegovy or mounjaro which is better, our clinical approach focuses on matching medication characteristics to your individual needs and circumstances. We provide detailed switching consultations that consider your medication history, side effect experiences, lifestyle factors, and treatment goals. New customers benefit from code FIRST40 applied at checkout, whilst returning customers use DOSE25 for transparent pricing on either medication option. Both Wegovy and Mounjaro are available through our platform, ensuring you can access either treatment based on clinical suitability rather than stock limitations. Our prescribers collaborate with your existing healthcare team when coordinating medication switches, maintaining continuity of care throughout your transition. Visit https://everydaymeds.co.uk/collections/weight-loss to begin your clinical assessment and explore switching options with expert guidance.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
